Corcept Therapeutics Incorporated Stock Price History
| CORT Stock | USD 57.11 1.21 2.07% |
Below is the normalized historical share price chart for Corcept Therapeutics Incorporated extending back to April 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Corcept Therapeutics stands at 57.11, as last reported on the 27th of March, with the highest price reaching 58.76 and the lowest price hitting 56.52 during the day.
If you're considering investing in Corcept Stock, it is important to understand the factors that can impact its price. Corcept Therapeutics appears to be very steady, given 3 months investment horizon. Corcept Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0569, which signifies that the company had a 0.0569 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Corcept Therapeutics Incorporated, which you can use to evaluate the volatility of the firm. Please makes use of Corcept Therapeutics' Mean Deviation of 2.41, downside deviation of 3.14, and Risk Adjusted Performance of 0.0535 to double-check if our risk estimates are consistent with your expectations.
At this time, Corcept Therapeutics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 882.6 M in 2025, whereas Common Stock Total Equity is likely to drop slightly above 87.7 K in 2025. . At this time, Corcept Therapeutics' Price Earnings Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 8.04 in 2025, whereas Price To Sales Ratio is likely to drop 7.32 in 2025. Corcept Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of April 2004 | 200 Day MA 47.5925 | 50 Day MA 61.4014 | Beta 0.612 |
Corcept |
Sharpe Ratio = 0.0569
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CORT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.58 actual daily | 31 69% of assets are more volatile |
Expected Return
| 0.2 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Corcept Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Corcept Therapeutics by adding it to a well-diversified portfolio.
Price Book 9.0539 | Enterprise Value Ebitda 41.7723 | Price Sales 9.115 | Shares Float 86.9 M | Wall Street Target Price 99.75 |
Corcept Therapeutics Stock Price History Chart
There are several ways to analyze Corcept Stock price data. The simplest method is using a basic Corcept candlestick price chart, which shows Corcept Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 13, 2025 | 73.61 |
| Lowest Price | January 10, 2025 | 49.85 |
Corcept Therapeutics March 27, 2025 Stock Price Synopsis
Various analyses of Corcept Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Corcept Stock. It can be used to describe the percentage change in the price of Corcept Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Corcept Stock.| Corcept Therapeutics Price Action Indicator | (1.14) | |
| Corcept Therapeutics Price Daily Balance Of Power | (0.54) | |
| Corcept Therapeutics Accumulation Distribution | 24,262 | |
| Corcept Therapeutics Price Rate Of Daily Change | 0.98 |
Corcept Therapeutics March 27, 2025 Stock Price Analysis
Corcept Stock Price History Data
The price series of Corcept Therapeutics for the period between Fri, Dec 27, 2024 and Thu, Mar 27, 2025 has a statistical range of 23.76 with a coefficient of variation of 11.42. The prices are distributed with arithmetic mean of 58.97. The median price for the last 90 days is 58.0.| Open | High | Low | Close | Volume | ||
| 03/26/2025 | 58.26 | 58.76 | 56.52 | 57.11 | 636,435 | |
| 03/25/2025 | 59.50 | 60.04 | 57.86 | 58.32 | 663,493 | |
| 03/24/2025 | 59.96 | 61.09 | 59.37 | 59.47 | 834,034 | |
| 03/21/2025 | 56.74 | 59.14 | 56.33 | 58.66 | 1,943,522 | |
| 03/20/2025 | 57.32 | 59.72 | 57.02 | 57.59 | 882,526 | |
| 03/19/2025 | 56.07 | 58.61 | 55.64 | 58.00 | 805,353 | |
| 03/18/2025 | 57.45 | 57.88 | 56.10 | 56.50 | 722,552 | |
| 03/17/2025 | 55.01 | 58.48 | 55.01 | 57.88 | 1,049,741 | |
| 03/14/2025 | 55.51 | 56.83 | 54.12 | 56.01 | 753,585 | |
| 03/13/2025 | 55.29 | 55.55 | 54.18 | 54.85 | 691,744 | |
| 03/12/2025 | 57.47 | 57.95 | 54.40 | 55.00 | 1,038,417 | |
| 03/11/2025 | 56.57 | 57.56 | 55.04 | 55.42 | 1,332,758 | |
| 03/10/2025 | 53.60 | 56.56 | 52.95 | 56.40 | 1,365,133 | |
| 03/07/2025 | 54.16 | 56.18 | 52.45 | 55.40 | 1,439,425 | |
| 03/06/2025 | 54.37 | 56.11 | 53.82 | 54.30 | 1,679,061 | |
| 03/05/2025 | 56.02 | 57.11 | 54.66 | 55.49 | 1,230,034 | |
| 03/04/2025 | 58.72 | 60.32 | 55.80 | 55.99 | 1,889,313 | |
| 03/03/2025 | 61.39 | 61.39 | 57.82 | 59.07 | 1,739,108 | |
| 02/28/2025 | 60.19 | 61.04 | 59.12 | 60.58 | 1,359,625 | |
| 02/27/2025 | 61.00 | 64.66 | 59.25 | 59.85 | 2,111,699 | |
| 02/26/2025 | 61.61 | 64.25 | 61.59 | 63.37 | 1,316,557 | |
| 02/25/2025 | 61.60 | 61.71 | 59.09 | 61.23 | 1,267,113 | |
| 02/24/2025 | 63.94 | 64.19 | 60.50 | 61.81 | 1,304,107 | |
| 02/21/2025 | 65.90 | 66.48 | 63.19 | 63.54 | 1,206,530 | |
| 02/20/2025 | 73.05 | 74.00 | 64.34 | 65.09 | 1,981,825 | |
| 02/19/2025 | 73.85 | 75.00 | 71.52 | 73.53 | 807,533 | |
| 02/18/2025 | 73.63 | 74.50 | 71.50 | 72.60 | 592,348 | |
| 02/14/2025 | 74.00 | 74.61 | 72.00 | 72.72 | 816,305 | |
| 02/13/2025 | 70.13 | 73.75 | 69.55 | 73.61 | 950,846 | |
| 02/12/2025 | 66.62 | 70.68 | 66.28 | 70.15 | 641,309 | |
| 02/11/2025 | 67.92 | 70.27 | 67.77 | 68.11 | 577,223 | |
| 02/10/2025 | 68.08 | 68.66 | 67.34 | 67.54 | 619,229 | |
| 02/07/2025 | 68.06 | 70.01 | 67.17 | 68.01 | 654,887 | |
| 02/06/2025 | 68.11 | 69.40 | 67.41 | 68.04 | 888,420 | |
| 02/05/2025 | 67.02 | 68.93 | 66.78 | 68.45 | 715,865 | |
| 02/04/2025 | 65.97 | 67.85 | 65.95 | 66.91 | 776,123 | |
| 02/03/2025 | 65.10 | 67.94 | 64.66 | 66.55 | 1,226,341 | |
| 01/31/2025 | 70.05 | 71.29 | 65.35 | 66.92 | 1,507,036 | |
| 01/30/2025 | 63.33 | 70.60 | 62.28 | 69.90 | 1,877,386 | |
| 01/29/2025 | 60.39 | 61.87 | 60.06 | 61.53 | 430,639 | |
| 01/28/2025 | 60.53 | 61.06 | 59.01 | 60.66 | 493,079 | |
| 01/27/2025 | 59.77 | 61.44 | 59.32 | 60.30 | 824,119 | |
| 01/24/2025 | 62.29 | 62.29 | 59.35 | 59.99 | 1,006,669 | |
| 01/23/2025 | 58.87 | 62.98 | 58.28 | 62.29 | 1,058,565 | |
| 01/22/2025 | 61.21 | 61.63 | 58.02 | 59.03 | 1,352,922 | |
| 01/21/2025 | 56.33 | 61.24 | 55.90 | 61.11 | 1,100,608 | |
| 01/17/2025 | 54.93 | 55.36 | 53.76 | 55.31 | 742,443 | |
| 01/16/2025 | 53.70 | 54.81 | 53.30 | 54.44 | 677,317 | |
| 01/15/2025 | 52.82 | 53.88 | 52.45 | 53.78 | 531,232 | |
| 01/14/2025 | 51.58 | 52.56 | 50.91 | 51.66 | 1,085,654 | |
| 01/13/2025 | 49.48 | 51.13 | 49.00 | 51.06 | 590,434 | |
| 01/10/2025 | 50.54 | 50.94 | 49.16 | 49.85 | 1,013,988 | |
| 01/08/2025 | 50.93 | 52.09 | 50.50 | 51.69 | 375,019 | |
| 01/07/2025 | 51.50 | 52.17 | 50.29 | 51.25 | 625,323 | |
| 01/06/2025 | 50.82 | 51.78 | 49.80 | 51.66 | 691,442 | |
| 01/03/2025 | 50.08 | 51.15 | 49.76 | 50.86 | 942,854 | |
| 01/02/2025 | 50.62 | 52.00 | 49.42 | 49.97 | 843,821 | |
| 12/31/2024 | 51.86 | 51.86 | 50.02 | 50.39 | 765,696 | |
| 12/30/2024 | 51.95 | 51.95 | 50.15 | 50.85 | 596,318 | |
| 12/27/2024 | 53.36 | 53.36 | 51.87 | 52.47 | 427,076 | |
| 12/26/2024 | 52.35 | 53.67 | 51.74 | 53.63 | 461,618 |
About Corcept Therapeutics Stock history
Corcept Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Corcept is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Corcept Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Corcept Therapeutics stock prices may prove useful in developing a viable investing in Corcept Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 113.5 M | 84.9 M | |
| Net Income Applicable To Common Shares | 116.5 M | 122.3 M |
Corcept Therapeutics Quarterly Net Working Capital |
|
Corcept Therapeutics Stock Technical Analysis
Corcept Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Corcept Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Corcept Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Corcept Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Corcept to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0535 | |||
| Jensen Alpha | 0.1833 | |||
| Total Risk Alpha | 0.1884 | |||
| Sortino Ratio | 0.0576 | |||
| Treynor Ratio | 0.0872 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Corcept Stock Analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.